Logo 1 Logo 2

Clinical Trial Details

Trial ID: L1144
Source ID: NCT00596167
Associated Drug: Intravenous Antibiotics
Title: Intradialytic Drug Removal by Short-daily Hemodialysis
Acronym:
Status: COMPLETED
Study Results: YES
Results: https://ClinicalTrials.gov/show/NCT00596167/results
Conditions: End Stage Renal Disease|Infection
Interventions: DRUG: Intravenous antibiotics
Outcome Measures: Primary: Intradialytic Clearance of Levofloxacin, Gentamicin and Vancomycin in Patients Receiving Short-daily Hemodialysis, The intradialytic clearance of levofloxacin, gentamicin and vancomycin will be determined in patients receiving short-daily hemodialysis. (Of important note, due to technical issues the levofloxacin data was not able to be used for the analysis. Only the gentamicin and vancomycin data was analyzed.), Serum concentrations for each drug will be determined from blood samples at 0 (pre-infusion), 30, 60 minutes (end of infusion). |
Sponsor/Collaborators: Sponsor: Indiana University School of Medicine
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 6
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
Start Date: 2007-09
Completion Date: 2009-09
Results First Posted: 2016-03-25
Last Update Posted: 2016-03-25
Locations: Indiana University School of Medicine, Indianapolis, Indiana, 46202, United States
URL: https://clinicaltrials.gov/show/NCT00596167